These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 15486983)

  • 41. On getting there from here.
    McKnight SL
    Science; 2010 Dec; 330(6009):1338-9. PubMed ID: 21127243
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Discovery and validation of colonic tumor-associated proteins via metabolic labeling and stable isotopic dilution.
    Huttlin EL; Chen X; Barrett-Wilt GA; Hegeman AD; Halberg RB; Harms AC; Newton MA; Dove WF; Sussman MR
    Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17235-40. PubMed ID: 19805096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Correspondence re: T. Zhang et al., Evidence that APC regulates survivin expression: a possible mechanism contributing to the stem cell origin of colon cancer. Cancer Res., 61: 8664-8667, 2001.
    Daidone MG; Costa A; Frattini M; Balestra D; Bertario L; Pierotti MA
    Cancer Res; 2004 Jan; 64(2):776-7; author reply 777-9. PubMed ID: 14744799
    [No Abstract]   [Full Text] [Related]  

  • 44. Assessment of histone tail modifications and transcriptional profiling during colon cancer progression reveals a global decrease in H3K4me3 activity.
    Triff K; McLean MW; Konganti K; Pang J; Callaway E; Zhou B; Ivanov I; Chapkin RS
    Biochim Biophys Acta Mol Basis Dis; 2017 Jun; 1863(6):1392-1402. PubMed ID: 28315775
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling.
    Agrawal D; Chen T; Irby R; Quackenbush J; Chambers AF; Szabo M; Cantor A; Coppola D; Yeatman TJ
    J Natl Cancer Inst; 2002 Apr; 94(7):513-21. PubMed ID: 11929952
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Biological and functional analysis of statistically significant pathways deregulated in colon cancer by using gene expression profiles.
    Distaso A; Abatangelo L; Maglietta R; Creanza TM; Piepoli A; Carella M; D'Addabbo A; Ancona N
    Int J Biol Sci; 2008; 4(6):368-78. PubMed ID: 18953405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cellular expression patterns of genes upregulated in murine and human colonic neoplasms.
    Chen X; Ehrhardt WM; Halberg RB; Aronow BJ; Dove WF
    J Histochem Cytochem; 2008 May; 56(5):433-41. PubMed ID: 18180384
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Metabolomics of ApcMin/+ mice genetically susceptible to intestinal cancer.
    Dazard JE; Sandlers Y; Doerner SK; Berger NA; Brunengraber H
    BMC Syst Biol; 2014 Jun; 8():72. PubMed ID: 24954394
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intestinal neoplasia induced by low dietary folate is associated with altered tumor expression profiles and decreased apoptosis in mouse normal intestine.
    Garcia-Crespo D; Knock E; Jabado N; Rozen R
    J Nutr; 2009 Mar; 139(3):488-94. PubMed ID: 19176749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Systemic Chromosome Instability Resulted in Colonic Transcriptomic Changes in Metabolic, Proliferation, and Stem Cell Regulators in Sgo1-/+ Mice.
    Rao CV; Sanghera S; Zhang Y; Biddick L; Reddy A; Lightfoot S; Janakiram NB; Mohammed A; Dai W; Yamada HY
    Cancer Res; 2016 Feb; 76(3):630-42. PubMed ID: 26833665
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Microarray analysis to reveal genes involved in colon carcinogenesis.
    Joyce T; Pintzas A
    Expert Opin Pharmacother; 2007 May; 8(7):895-900. PubMed ID: 17472535
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The potential role of gene profiling in the management of early-stage colon cancer.
    Chu E
    Clin Colorectal Cancer; 2006 Jul; 6(2):99. PubMed ID: 16945164
    [No Abstract]   [Full Text] [Related]  

  • 53. [A new cancer gene--with drama].
    Rehfeld JF
    Ugeskr Laeger; 1994 Feb; 156(6):823-5. PubMed ID: 8016990
    [No Abstract]   [Full Text] [Related]  

  • 54. Multistep carcinogenesis of the colon in Apc(Min/+) mouse.
    Yamada Y; Mori H
    Cancer Sci; 2007 Jan; 98(1):6-10. PubMed ID: 17052257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. ApcMin: a mouse model for intestinal and mammary tumorigenesis.
    Moser AR; Luongo C; Gould KA; McNeley MK; Shoemaker AR; Dove WF
    Eur J Cancer; 1995; 31A(7-8):1061-4. PubMed ID: 7576992
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A dominant mutation that predisposes to multiple intestinal neoplasia in the mouse.
    Moser AR; Pitot HC; Dove WF
    Science; 1990 Jan; 247(4940):322-4. PubMed ID: 2296722
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Apc mice: models, modifiers and mutants.
    McCart AE; Vickaryous NK; Silver A
    Pathol Res Pract; 2008; 204(7):479-90. PubMed ID: 18538487
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Muscle inactivation of mTOR causes metabolic and dystrophin defects leading to severe myopathy.
    Risson V; Mazelin L; Roceri M; Sanchez H; Moncollin V; Corneloup C; Richard-Bulteau H; Vignaud A; Baas D; Defour A; Freyssenet D; Tanti JF; Le-Marchand-Brustel Y; Ferrier B; Conjard-Duplany A; Romanino K; Bauché S; Hantaï D; Mueller M; Kozma SC; Thomas G; Rüegg MA; Ferry A; Pende M; Bigard X; Koulmann N; Schaeffer L; Gangloff YG
    J Cell Biol; 2009 Dec; 187(6):859-74. PubMed ID: 20008564
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Application of the Apc(Min/+) mouse model for studying inflammation-associated intestinal tumor.
    Wang L; Zhang Q
    Biomed Pharmacother; 2015 Apr; 71():216-21. PubMed ID: 25960239
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The AOM/DSS murine model for the study of colon carcinogenesis: From pathways to diagnosis and therapy studies.
    De Robertis M; Massi E; Poeta ML; Carotti S; Morini S; Cecchetelli L; Signori E; Fazio VM
    J Carcinog; 2011 Mar; 10():9. PubMed ID: 21483655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.